Niki BioSolutions, Inc. (NIKI) Stock Analysis & Investment Frameworks
Niki BioSolutions, Inc. (NIKI) stock analysis on Invetso. Review Niki BioSolutions, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Niki BioSolutions, Inc. Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Niki BioSolutions, Inc. Key Financial Metrics
- Market Cap: $487808.00
- Revenue: $N/A
- ROE: -5.94%
- ROIC: -2.30%
- Dividend Yield: N/A
About Niki BioSolutions, Inc.
Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets. Its work spans from treatments for diseases with unmet medical needs, particularly in oncology and infectious diseases, to the development of innovative, blood-based diagnostic tests for brain health and other conditions.
Niki BioSolutions, Inc. Investment Frameworks
Invetso analyzes Niki BioSolutions, Inc. (NIKI) across the following frameworks:
- Niki BioSolutions, Inc. 10Y Growth Potential
- Niki BioSolutions, Inc. Scenario Analysis
- Niki BioSolutions, Inc. Risks & Opportunities
- Niki BioSolutions, Inc. Economic Moat
- Niki BioSolutions, Inc. Business Model
- Niki BioSolutions, Inc. Management
- Niki BioSolutions, Inc. SWOT Analysis
- Niki BioSolutions, Inc. Porter's 5 Forces
- Niki BioSolutions, Inc. PESTLE Analysis
- Niki BioSolutions, Inc. ESG Analysis
